STUELPNAGEL JOHN R (CIK 1189140) reported 7 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-08). Recent activity: Sell TXG (7,012 shares), Sell TXG (6,814 shares), Sell TXG (6,174 shares), Sell TXG (17,000 shares), Sell TXG (3,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-08 | 10x Genomics, Inc. (TXG) | Director | Sell | 7,012 | $425,333 |
| 2026-09-08 | 10x Genomics, Inc. (TXG) | Director | Sell | 6,814 | $423,205 |
| 2026-09-08 | 10x Genomics, Inc. (TXG) | Director | Sell | 6,174 | $386,533 |
| 2026-08-13 | 10x Genomics, Inc. (TXG) | Director | Sell | 17,000 | $978,880 |
| 2026-08-13 | 10x Genomics, Inc. (TXG) | Director | Sell | 3,000 | $176,175 |
| 2026-06-08 | 10x Genomics, Inc. (TXG) | Director | Buy | 8,829 | $0 |
| 2025-06-05 | 10x Genomics, Inc. (TXG) | Director | Buy | 15,357 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-09-08